PMID- 38064816 OWN - NLM STAT- MEDLINE DCOM- 20240118 LR - 20240118 IS - 1878-1705 (Electronic) IS - 1567-5769 (Linking) VI - 127 DP - 2024 Jan 25 TI - Cold-inducible RNA-binding protein induces inflammatory responses via NF-kappaB signaling pathway in normal human bronchial epithelial cells infected with streptococcus pneumoniae. PG - 111338 LID - S1567-5769(23)01665-X [pii] LID - 10.1016/j.intimp.2023.111338 [doi] AB - BACKGROUND: Community-acquired pneumonia causes significant illness and death worldwide, requiring further investigation and intervention. The invasion of Streptococcus pneumoniae (S. pneumoniae, S.p) can lead to serious conditions like meningitis, sepsis, or pneumonia. Extracellular Cold-inducible RNA-binding protein (eCIRP) acts as a damage-associated molecular pattern that triggers inflammatory responses and plays an important role in both acute and chronic inflammatory diseases. It remains unclear whether CIRP is involved in the process of S. pneumoniae infection in normal human bronchial epithelial cells (BEAS-2B). METHODS: Cell counting kit (CCK)-8 assay was used to detect the activity of BEAS-2B cells. The subcellular localization of CIRP was detected by immunofluorescence. The mRNA and protein levels of CIRP, nuclear factor kappa-B (NF-kappaB) p65, toll like receptor-4 (TLR4), interleukin-6 (IL-6) were detected using quantitative real-time PCR (PCR) and Western Blot (WB). The protein expressions of CIRP, IL-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha) and monocyte chemoattractant protein-1 (MCP-1) were assessed by enzyme-linked immunosorbent assay (ELISA). RESULTS: CIRP affects the activity of BEAS-2B cells induced by S. pneumoniae infection. After infection, CIRP translocates from the nucleus to the cytoplasm, thereby inducing the production of pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha, and MCP-1). Additionally, the NF-kappaB p65 protein increases in infected cells but decreases with si-CIRP interference. Treatment with TLR4 neutralizing antibodies or NF-kappaB inhibitor effectively reduces the expressions of IL-1beta, IL-6, TNF-alpha, and MCP-1. CONCLUSIONS: The infection with S. pneumoniae upregulates CIRP expression and translocates it from the nucleus to the cytoplasm in BEAS-2B cells, leading to the release of proinflammatory factors via activation of NF-kappaB signaling pathway. CIRP as a key mediator in S. pneumoniae-induced inflammation offers potential targets for therapeutic intervention against community-acquired pneumonia. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Zhang, Rong AU - Zhang R AD - Emergency Department of the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, China. FAU - Fang, Kun AU - Fang K AD - Emergency Department of the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, China. FAU - Mu, Chunyan AU - Mu C AD - Xuzhou Medical University, Xuzhou, Jiangsu 221000, China. FAU - Zhang, Liang AU - Zhang L AD - Emergency Department of the Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, China. Electronic address: qilipiaoxiangqq@163.com. LA - eng PT - Journal Article DEP - 20231207 PL - Netherlands TA - Int Immunopharmacol JT - International immunopharmacology JID - 100965259 RN - 0 (NF-kappa B) RN - 0 (Toll-Like Receptor 4) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (RNA-Binding Proteins) SB - IM MH - Humans MH - *NF-kappa B/metabolism MH - Streptococcus pneumoniae MH - Toll-Like Receptor 4/genetics/metabolism MH - Interleukin-6/metabolism MH - Tumor Necrosis Factor-alpha/metabolism MH - Signal Transduction MH - Epithelial Cells/metabolism MH - *Pneumonia/metabolism MH - RNA-Binding Proteins/metabolism OTO - NOTNLM OT - BEAS-2B OT - Cold-inducible RNA-binding protein OT - NF-kappaB signaling OT - Streptococcus pneumoniae COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/12/09 05:43 MHDA- 2024/01/18 06:43 CRDT- 2023/12/08 18:02 PHST- 2023/08/28 00:00 [received] PHST- 2023/11/20 00:00 [revised] PHST- 2023/11/29 00:00 [accepted] PHST- 2024/01/18 06:43 [medline] PHST- 2023/12/09 05:43 [pubmed] PHST- 2023/12/08 18:02 [entrez] AID - S1567-5769(23)01665-X [pii] AID - 10.1016/j.intimp.2023.111338 [doi] PST - ppublish SO - Int Immunopharmacol. 2024 Jan 25;127:111338. doi: 10.1016/j.intimp.2023.111338. Epub 2023 Dec 7.